Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nanolytics

1999 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Provider of nano-droplet microfluidics. The company provides proprietary novel technologies like microfluidics which can be used for fabricating bio-chips, used for analyzing biological and environmental samples.

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Primary Office
  • 5905 Triangle Drive
  • Raleigh, NC 27617
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nanolytics’s full profile, request a free trial.

Nanolytics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Feb-2007 00000 Completed Generating Revenue
4. Angel (individual) 00000 00000 Completed Generating Revenue
3. Grant 01-Jan-2006 00000 Completed Generating Revenue
2. Grant 01-Jan-2004 $117K Completed Startup
1. Grant 01-Jan-2000 $300K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Nanolytics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0

Nanolytics Executive Team (2)

Name Title Board
Seat
Contact
Info
Alexander Shenderov Ph.D Chief Technology Officer & Co-Founder
Varvara Grichko Ph.D Co-Founder